Related Experiment Video
Updated: Feb 28, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Summary
Menopausal weight gain is often linked to reduced activity. Lean women can manage weight by controlling diet and increasing exercise, while overweight women may need very low-energy diets and long-term behavior changes for significant weight loss.
Area of Science:
- Reproductive Endocrinology
- Metabolic Health
- Weight Management
Background:
- Menopause is frequently associated with weight gain in women.
- While modest weight gain is common and manageable, overweight and obese women often experience more significant weight accumulation.
- This weight gain is particularly pronounced as women approach menopause.
Purpose of the Study:
- To elucidate the underlying causes of menopausal weight gain.
- To present a structured approach for achieving and maintaining substantial weight reduction during and after menopause.
Main Methods:
- Analysis of factors contributing to menopausal weight gain.
- Description of dietary and lifestyle interventions for weight management.
- Discussion of pharmacotherapy options for appetite suppression.
Main Results:
- Reduced spontaneous physical activity is a primary driver of menopausal weight gain.
- Lifestyle adjustments (dietary control, increased physical activity) are effective for lean women.
- Overweight and obese women benefit from very low-energy diets for initial rapid weight loss.
Conclusions:
- Menopausal weight gain is primarily attributed to decreased spontaneous activity.
- Preventive strategies for lean women involve energy intake control and enhanced physical activity.
- Sustainable weight loss for overweight/obese women requires very low-energy diets followed by lifelong behavioral modification, potentially with pharmacotherapy.
Related Concept Videos
Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients
316
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Hormonal Regulation of the Menstrual Cycle
1.9K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Atherosclerosis III: Management
520
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520

